386 related articles for article (PubMed ID: 25333353)
1. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
Liu L; Hou L; Gu S; Zuo X; Meng D; Luo M; Zhang X; Huang S; Zhao X
Oncol Rep; 2015 Jan; 33(1):297-303. PubMed ID: 25333353
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
Liu L; Ju Y; Wang J; Zhou R
Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio.
Du L; Fei Z; Song S; Wei N
Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
Yoshimura H; Yoshida H; Matsuda S; Ryoke T; Ohta K; Ohmori M; Yamamoto S; Kiyoshima T; Kobayashi M; Sano K
Mol Med Rep; 2019 Aug; 20(2):1139-1148. PubMed ID: 31173211
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation.
Manohar M; Fatima I; Saxena R; Chandra V; Sankhwar PL; Dwivedi A
J Nutr Biochem; 2013 Jun; 24(6):940-7. PubMed ID: 22959059
[TBL] [Abstract][Full Text] [Related]
6. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
7. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G
Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
Park SB; Bae JW; Kim JM; Lee SG; Han M
Int J Mol Med; 2012 Nov; 30(5):1211-8. PubMed ID: 22923012
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Lee JC; Chung LC; Chen YJ; Feng TH; Chen WT; Juang HH
Cancer Lett; 2015 May; 360(2):310-8. PubMed ID: 25721086
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25.
Zan L; Chen Q; Zhang L; Li X
Bioengineered; 2019 Dec; 10(1):374-382. PubMed ID: 31431131
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
[TBL] [Abstract][Full Text] [Related]
13. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
Shankar S; Marsh L; Srivastava RK
Mol Cell Biochem; 2013 Jan; 372(1-2):83-94. PubMed ID: 22971992
[TBL] [Abstract][Full Text] [Related]
14. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.
Wei R; Mao L; Xu P; Zheng X; Hackman RM; Mackenzie GG; Wang Y
Food Funct; 2018 Nov; 9(11):5682-5696. PubMed ID: 30310905
[TBL] [Abstract][Full Text] [Related]
15. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
16. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
Chen NG; Lu CC; Lin YH; Shen WC; Lai CH; Ho YJ; Chung JG; Lin TH; Lin YC; Yang JS
Oncol Rep; 2011 Oct; 26(4):939-47. PubMed ID: 21743966
[TBL] [Abstract][Full Text] [Related]
17. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
[TBL] [Abstract][Full Text] [Related]
18. Nimesulide inhibits the growth of human esophageal carcinoma cells by inactivating the JAK2/STAT3 pathway.
Liu JR; Wu WJ; Liu SX; Zuo LF; Wang Y; Yang JZ; Nan YM
Pathol Res Pract; 2015 Jun; 211(6):426-34. PubMed ID: 25724470
[TBL] [Abstract][Full Text] [Related]
19. α-Hederin Induces Apoptosis of Esophageal Squamous Cell Carcinoma via an Oxidative and Mitochondrial-Dependent Pathway.
Wang J; Wu D; Zhang J; Liu H; Wu J; Dong W
Dig Dis Sci; 2019 Dec; 64(12):3528-3538. PubMed ID: 31273592
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
